Evaluation of a Commercial Rapid Molecular Point-of-Care Assay for Differential Diagnosis Between SARS-CoV-2 and Flu A/B Infections in a Pediatric Setting
VIRUSES-BASEL(2024)
Key words
point-of-care testing,SARS-CoV-2,influenza A/B,rapid molecular assay,ID NOW,pediatric respiratory infections
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined